Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis (REViVALS-1A)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04632225
Recruitment Status : Recruiting
First Posted : November 17, 2020
Last Update Posted : May 19, 2021
Sponsor:
Information provided by (Responsible Party):
Helixmith Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : December 31, 2022